Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-12
DOI
10.1007/s00277-021-04617-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytoreductive treatment in patients with CALR ‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
- (2020) Alberto Alvarez‐Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
- (2019) Natasha Szuber et al. MAYO CLINIC PROCEEDINGS
- Essential Thrombocythemia
- (2019) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality
- (2018) Sofia Sideri et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Essential thrombocythaemia with mutation inMPL: clinicopathological correlation and comparison withJAK2V617F-mutated andCALR-mutated genotypes
- (2018) Alberto Alvarez-Larran et al. JOURNAL OF CLINICAL PATHOLOGY
- Essential thrombocythemia treatment algorithm 2018
- (2018) Ayalew Tefferi et al. Blood Cancer Journal
- MPL-mutated essential thrombocythemia: a morphologic reappraisal
- (2018) Natasha Szuber et al. Blood Cancer Journal
- Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia
- (2016) Yoseph C. Elala et al. AMERICAN JOURNAL OF HEMATOLOGY
- Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients
- (2016) Mahnur Haider et al. AMERICAN JOURNAL OF HEMATOLOGY
- Publication Bias
- (2016) Jarrod E. Dalton et al. ANESTHESIA AND ANALGESIA
- Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
- (2015) C. Al Assaf et al. HAEMATOLOGICA
- The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis
- (2015) Youwen Qin et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
- (2015) Malin Hultcrantz et al. JOURNAL OF CLINICAL ONCOLOGY
- Understanding Relative Risk, Odds Ratio, and Related Terms: As Simple as It Can Get
- (2015) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
- (2015) F Palandri et al. LEUKEMIA
- Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
- (2015) T Barbui et al. Blood Cancer Journal
- Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
- (2015) C. Al Assaf et al. HAEMATOLOGICA
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
- (2014) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history
- (2014) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Calreticulin mutations and long-term survival in essential thrombocythemia
- (2014) A Tefferi et al. LEUKEMIA
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
- (2013) G. Rotunno et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
- (2012) T. Barbui et al. BLOOD
- A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
- (2012) F. Passamonti et al. BLOOD
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
- (2011) G Finazzi et al. LEUKEMIA
- Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study
- (2009) F. Girodon et al. HAEMATOLOGICA
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More